These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 17606937

  • 1. Rate of methadone use among Aboriginal opioid injection drug users.
    Wood E, Montaner JS, Li K, Barney L, Tyndall MW, Kerr T.
    CMAJ; 2007 Jul 03; 177(1):37-40. PubMed ID: 17606937
    [Abstract] [Full Text] [Related]

  • 2. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT.
    CMAJ; 2002 Apr 02; 166(7):894-9. PubMed ID: 11949985
    [Abstract] [Full Text] [Related]

  • 4. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
    Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E.
    Subst Use Misuse; 2006 Apr 02; 41(2):199-210. PubMed ID: 16393742
    [Abstract] [Full Text] [Related]

  • 5. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT, Tait RJ, Hulse GK.
    Arch Gen Psychiatry; 2008 Apr 02; 65(4):457-65. PubMed ID: 18391134
    [Abstract] [Full Text] [Related]

  • 6. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.
    Wood E, Kerr T, Palepu A, Zhang R, Strathdee SA, Tyndall MW, Montaner JS, Hogg RS.
    J Infect; 2006 Apr 02; 52(4):233-6. PubMed ID: 16169594
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T, Marsh D, Li K, Montaner J, Wood E.
    Drug Alcohol Depend; 2005 Dec 12; 80(3):329-35. PubMed ID: 15964714
    [Abstract] [Full Text] [Related]

  • 8. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
    Fairbairn N, Wood E, Stoltz JA, Li K, Montaner J, Kerr T.
    Public Health; 2008 Jan 12; 122(1):70-8. PubMed ID: 17645904
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
    Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O'Shaughnessy MV, Schechter MT.
    CMAJ; 2003 Jan 07; 168(1):19-24. PubMed ID: 12515780
    [Abstract] [Full Text] [Related]

  • 10. High pregnancy rates and reproductive health indicators among female injection-drug users in Vancouver, Canada.
    Weber AE, Tyndall MW, Spittal PM, Li K, Coulter S, O'Shaughnessy MV, Schechter MT.
    Eur J Contracept Reprod Health Care; 2003 Mar 07; 8(1):52-8. PubMed ID: 12725675
    [Abstract] [Full Text] [Related]

  • 11. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May 07; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 12. Factors associated with geographic migration among a cohort of injection drug users.
    Rachlis BS, Hogg RS, Wood E, Li K, Kerr T.
    Health Place; 2008 Sep 07; 14(3):536-43. PubMed ID: 18410717
    [Abstract] [Full Text] [Related]

  • 13. Effect of methadone treatment on incarceration rates among injection drug users.
    Werb D, Kerr T, Marsh D, Li K, Montaner J, Wood E.
    Eur Addict Res; 2008 Sep 07; 14(3):143-9. PubMed ID: 18552490
    [Abstract] [Full Text] [Related]

  • 14. Do supervised injecting facilities attract higher-risk injection drug users?
    Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T.
    Am J Prev Med; 2005 Aug 07; 29(2):126-30. PubMed ID: 16005809
    [Abstract] [Full Text] [Related]

  • 15. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users.
    Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E.
    Drug Alcohol Depend; 2007 Feb 23; 87(1):39-45. PubMed ID: 16959438
    [Abstract] [Full Text] [Related]

  • 16. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
    Milloy MJ, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, Wood E.
    Am J Drug Alcohol Abuse; 2008 Feb 23; 34(4):499-509. PubMed ID: 18584579
    [Abstract] [Full Text] [Related]

  • 17. The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.
    Yang J, Oviedo-Joekes E, Christian KW, Li K, Louie M, Schechter M, Spittal P.
    Drug Alcohol Rev; 2011 Nov 23; 30(6):645-51. PubMed ID: 21355933
    [Abstract] [Full Text] [Related]

  • 18. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M, McIntosh J, McKeganey N, Robertson M.
    Public Health; 2008 Oct 23; 122(10):1013-9. PubMed ID: 18490036
    [Abstract] [Full Text] [Related]

  • 19. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.
    Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T.
    Addiction; 2007 Jun 23; 102(6):916-9. PubMed ID: 17523986
    [Abstract] [Full Text] [Related]

  • 20. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, Montaner JS.
    HIV Med; 2008 Aug 23; 9(7):503-7. PubMed ID: 18484977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.